Drug
Enmetazobactam clinical trials
Also written AAI101.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2017 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Allecra (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses enmetazobactam is read from its arms, and is right about nine times in ten.
Testing it · 3
- Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy SubjectsCompletedPhase 1AllecraNCT03680352Written as cefepime/AAI101
- Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)CompletedPhase 1AllecraNCT03680378Written as Cefepime 2 gram
- Investigation of AAI101 Safety, Tolerability & PK in Healthy VolunteersCompletedPhase 1AllecraNCT03685084Written as AAI101 i.v.
Codes
What other systems call enmetazobactam · ClinicalTrials.gg INT001258
- MeSH (NLM) C000656730enmetazobactamConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 80VUN7L00CENMETAZOBACTAMConfirmed FDA, NLM, Wikidata
- Wikidata Q124721115enmetazobactamConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171696EnmetazobactamOne source FDA
- DrugBank DB18716One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000656730 | enmetazobactam | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 80VUN7L00C | ENMETAZOBACTAM | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q124721115 | enmetazobactam | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171696 | Enmetazobactam | One source FDA |
| DrugBank | DB18716 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.